SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-007176
Filing Date
2024-01-29
Accepted
2024-01-29 08:00:28
Documents
15
Period of Report
2024-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192211-8k_180life.htm   iXBRL 8-K 50694
  Complete submission text file 0001213900-24-007176.txt   272307

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20240123.xsd EX-101.SCH 3787
3 XBRL DEFINITION FILE atnf-20240123_def.xml EX-101.DEF 26629
4 XBRL LABEL FILE atnf-20240123_lab.xml EX-101.LAB 36680
5 XBRL PRESENTATION FILE atnf-20240123_pre.xml EX-101.PRE 25253
16 EXTRACTED XBRL INSTANCE DOCUMENT ea192211-8k_180life_htm.xml XML 5737
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 24570136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)